Extracellular vesicles and cancer multidrug resistance: undesirable Intercellular messengers?
dc.citation.title | Life | es |
dc.citation.volume | 13 | es |
dc.creator | Bucci Muñoz, María | |
dc.creator | Gola, Aldana Magalí | |
dc.creator | Rigalli, Juan Pablo | |
dc.creator | Ceballos Mancini, María Paula | |
dc.creator | Ruiz, María Laura | |
dc.date.accessioned | 2023-09-07T17:35:16Z | |
dc.date.available | 2023-09-07T17:35:16Z | |
dc.date.issued | 2023-07-27 | |
dc.description | Cancer multidrug resistance (MDR) is one of the main mechanisms contributing to therapy failure and mortality. Overexpression of drug transporters of the ABC family (ATP-binding cassette) is a major cause of MDR. Extracellular vesicles (EVs) are nanoparticles released by most cells of the organism involved in cell–cell communication. Their cargo mainly comprises, proteins, nucleic acids, and lipids, which are transferred from a donor cell to a target cell and lead to phenotypical changes. In this article, we review the scientific evidence addressing the regulation of ABC transporters by EV-mediated cell–cell communication. MDR transfer from drug-resistant to drug-sensitive cells has been identified in several tumor entities. This was attributed, in some cases, to the direct shuttle of transporter molecules or its coding mRNA between cells. Also, EV-mediated transport of regulatory proteins (e.g., transcription factors) and noncoding RNAs have been indicated to induce MDR. Conversely, the transfer of a drug-sensitive phenotype via EVs has also been reported. Additionally, interactions between non-tumor cells and the tumor cells with an impact on MDR are presented. Finally, we highlight uninvestigated aspects and possible approaches to exploiting this knowledge toward the identification of druggable processes and molecules and, ultimately, the development of novel therapeutic strategies. | es |
dc.description.fil | Fil: Bucci Muñoz, María. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Fisiología Experimental (IFISE-CONICET); Argentina. | es |
dc.description.fil | Fil: Gola, Aldana Magalí. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Fisiología Experimental (IFISE-CONICET); Argentina. | es |
dc.description.fil | Fil: Rigalli, Juan Pablo. Heidelberg University Hospital. Department of Clinical Pharmacology and Pharmacoepidemiology; Germany. | es |
dc.description.fil | Fil: Ceballos Mancini, María Paula. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Fisiología Experimental (IFISE-CONICET); Argentina. | es |
dc.description.fil | Fil: Ruiz, María Laura. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Fisiología Experimental (IFISE-CONICET); Argentina. | es |
dc.description.sponsorship | Horizon 2020 Framework Programme (H2020): 101028473 | |
dc.description.sponsorship | German Research Foundation (DFG): RI-2673/2 | |
dc.description.sponsorship | Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET): PIP 2020-0386 | |
dc.description.sponsorship | Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT): PICT 2019-01837 | |
dc.format | application/pdf | |
dc.format.extent | 1-33 | es |
dc.identifier.issn | 2075-1729 | es |
dc.identifier.uri | http://hdl.handle.net/2133/26258 | |
dc.language.iso | eng | es |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | es |
dc.relation.publisherversion | https://doi.org/10.3390/life13081633 | |
dc.relation.publisherversion | https://www.mdpi.com/2075-1729/13/8/1633 | |
dc.rights | openAccess | es |
dc.rights.holder | Bucci Muñoz, María | es |
dc.rights.holder | Gola, Aldana Magalí | es |
dc.rights.holder | Rigalli, Juan Pablo | es |
dc.rights.holder | Ceballos Mancini, María Paula | es |
dc.rights.holder | Ruiz, María Laura | es |
dc.rights.holder | Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas | |
dc.rights.text | Attribution 4.0 International (CC BY 4.0) | es |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | ABC transporters | es |
dc.subject | Breast cancer resistance protein | es |
dc.subject | Drug resistance | es |
dc.subject | Extracellular vesicles | es |
dc.subject | Multidrug resistance associated protein | es |
dc.subject | P-glycoprotein | es |
dc.title | Extracellular vesicles and cancer multidrug resistance: undesirable Intercellular messengers? | es |
dc.type | article | |
dc.type | artículo | |
dc.type | publishedVersion | |
dc.type.collection | articulo | |
dc.type.version | publishedVersion | es |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Extracellular-Vesicles-and-Cancer-Multidrug-Resistance-Undesirable-Intercellular-MessengersLife.pdf
- Tamaño:
- 1.25 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- versión post print
Bloque de licencias
1 - 1 de 1
- Nombre:
- license.txt
- Tamaño:
- 3.59 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: